FACTBASEDINVESTING.COM - AFTER MARKET UPDATE

<<<Previous Mid Day Report	Next Mid Day Report >>>
<<<Previous After Market Report	Next After Market Report >>>

You are not logged in.
This means you CAN ONLY VIEW reports that were published prior to Friday, September 6, 2024.
You MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.

AFTER MARKET UPDATE - WEDNESDAY, APRIL 1ST, 2015

Previous After Market Report Next After Market Report >>>

Indices				NYSE			Nasdaq
DOW	-77.94	17,698.18	-0.44%	Volume	781,451,430	-18%	Volume	1,723,861,780	+5%
NASDAQ	-20.65	4,880.23	-0.42%	Advancers	1,623	51%	Advancers	1,313	41%
S&P 500	-8.20	2,059.69	-0.40%	Decliners	1,433	45%	Decliners	1,745	55%
Russell 2000	-5.03	1,251.71	-0.40%	52 Wk Highs	77		52 Wk Highs	81
S&P 600	-1.39	718.81	-0.19%	52 Wk Lows	29		52 Wk Lows	63

Mixed Action as Major Averages Pulled Back
Kenneth J. Gruneisen - Passed the CAN SLIM® Master's Exam
Stocks finished lower on Wednesday. The Dow lost 77 points to 17,698. The S&P 500 declined 8 points to 2,059. The NASDAQ fell 20 points to 4,880. The volume totals were reported mixed, lighter on the NYSE and higher on the Nasdaq exchange versus the prior session totals. Advancers led decliners by an 8-7 margin on the NYSE, but decliners led advancers by almost 4-3 on the Nasdaq exchange. There were 29 high-ranked companies from the CANSLIM.net Leaders List that made new 52-week highs and appeared on the CANSLIM.net BreakOuts Page, down from the prior session total of 54 stocks. The list of new 52-week highs contracted yet still outnumbered new 52-week lows on the NYSE and the Nasdaq exchange. There were gains for only 3 of the 13 high-ranked companies currently on the Featured Stocks Page.

Concerning the M criteria, the major averages' endured recent distributional pressure which put the rally under pressure, however, their remains a healthy level of leadership (stocks hitting new 52-week highs). New buying efforts should only be made in stocks meeting all of the fundamental and technical guidelines the fact-based investment system.

PICTURED: The NYSE Composite Index is consolidating near its 50-day moving average (DMA) line. A multi-month upward trendline shows additional near-term support. The index has met stubborn resistance in the 11,100 area for the past year.

The major averages retreated but finished off session lows, amid mixed economic data. ADP's payrolls report disappointed analysts as only 189,000 jobs were added in March. Manufacturing for March was lackluster, a gauge of sentiment by Markit rose more than forecast, but a similar gauge by ISM unexpectedly declined. February’s construction spending fell 0.1%, as estimated, but vehicle sales for March topped projections.

Five of the 10 S&P 500 sectors finished lower. A rout in biotech had health care stocks down the most. Regeneron (RGEN -2.3%) and Vertex (VRTX -1.3%) fell. Industrials showed weakness as oil prices rallied. Delta (DAL -3.8%) and United (UAL -4.8%) fell. Energy was up the most and Schlumberger (SLB +1%) rose. Monsanto (MON 3.9%) was strong seed sales outweighed disappointing quarterly results.

Breadth was mixed on issues with the NYSE positive by 7-6 but the NASDAQ negative by 3-2. NYSE composite volume totaled more than 3.5 billion shares.

Treasuries rose as mixed data spurred rate hike delay speculation. The 10-year note advanced 18/32 to yield 1.86%.

Commodities were broadly higher. WTI crude rallied 4.3% to $49.63/barrel as production slowed, and COMEX gold gained 1.8% to $1204.30/ounce amid dollar weakness. In FOREX, the dollar lost 0.2% with the euro up 0.3% to $1.0761/EUR and the yen 0.4% stronger to ¥119.67/USD.

The Featured Stocks Page shows recent notes and Headline Links directing members to detailed analysis with data-packed graphs annotated by a Certified expert. See the Premium Member Homepage for archives to all prior pay reports published.

Kenneth J. Gruneisen started out as a licensed stockbroker in August 1987, a couple of months prior to the historic stock market crash that took the Dow Jones Industrial Average down -22.6% in a single day. He has published daily fact-based fundamental and technical analysis on high-ranked stocks online for two decades. Through FACTBASEDINVESTING.COM, Kenneth provides educational articles, news, market commentary, and other information regarding proven investment systems that work in good times and bad.

Comments contained in the body of this report are technical opinions only and are not necessarily those of Gruneisen Growth Corp. The material herein has been obtained from sources believed to be reliable and accurate, however, its accuracy and completeness cannot be guaranteed. Our firm, employees, and customers may effect transactions, including transactions contrary to any recommendation herein, or have positions in the securities mentioned herein or options with respect thereto. Any recommendation contained in this report may not be suitable for all investors and it is not to be deemed an offer or solicitation on our part with respect to the purchase or sale of any securities.

Commodity-Linked Groups Were Session's Best Gainers
Kenneth J. Gruneisen - Passed the CAN SLIM® Master's Exam

Energy-related shares edged higher as the Integrated Oil Index ($XOI +0.66%) and the Oil Services Index ($OSX +0.72%) both rose on Wednesday. The tech sector had a slightly negative bias as the Biotechnology Index ($BTK -0.96%), Semiconductor Index ($SOX -0.62%), and Networking Index ($NWX -0.30%) each ended lower. Financials shares were quiet as the Bank Index ($BKX -0.29%) edged lower and the Broker/Dealer Index ($XBD +0.18%) eked out a small gain.

Charts courtesy www.stockcharts.com

PICTURED: The Gold & Silver Index ($XAU +5.19%) was a standout gainer. It recently halted is slide above its Nov-Dec lows.

Industry Index	Symbol	Close	Change	% Change	YTD % Change
Oil Services	$OSX	191.49	+1.37	+0.72%	-9.19%
Integrated Oil	$XOI	1,339.38	+8.75	+0.66%	-0.65%
Semiconductor	$SOX	691.19	-4.29	-0.62%	+0.63%
Networking	$NWX	370.53	-1.13	-0.30%	+3.52%
Broker/Dealer	$XBD	189.05	+0.34	+0.18%	+2.39%
Retail	$RLX	1,112.91	-5.88	-0.53%	+7.76%
Gold & Silver	$XAU	68.90	+3.40	+5.19%	+0.17%
Bank	$BKX	71.95	-0.21	-0.29%	-3.11%
Biotech	$BTK	3,949.33	-38.26	-0.96%	+14.84%

Pullback With Higher Volume Toward 50-Day Moving Average
Kenneth J. Gruneisen - Passed the CAN SLIM® Master's Exam

Actavis plc (ACT -$1.19 or -0.40% to $296.43) is consolidating quietly, very extended from any sound base. It completed a new Public Offering on 2/25/15. It recently reported Dec '14 earnings +23%, below the +25% minimum guideline (C criteria) of the fact-based investment system. Like any stock, on pullbacks it is important to watch how it acts near its 50-day moving average (DMA) line. Its 50 DMA line ($290) defines support where violations would raise more serious concerns and trigger a technical sell signal.

ACT was last shown in this FSU section on 3/13/15 with annotated graphs under the headline, "Extended From Base After Completing New Public Offering". The Medical - Generic Drugs industry group currently has a 98 Group Relative Strength Rating. Leadership from other issues in the group is a reassuring sign concerning the L criteria. ACT was first highlighted in yellow in the 6/20/14 mid-day report (read here). Its annual earnings (A criteria) history has been strong. The number of top-rated funds owning its shares has been on the rise, up from 1,219 in Sep '13 to 1,994 in Dec '14, and its Up/Down Volume ratio of 1.9 is an unbiased indication its shares have been under accumulation over the past 50 days, reassuring signs concerning the I criteria.

Color Codes Explained :
Y - Better candidates highlighted by our staff of experts.
G - Previously featured in past reports as yellow but may no longer be buyable under the guidelines.

***Last / Change / Volume data in this table is the closing quote data***

Symbol/Exchange Company Name Industry Group	PRICE	CHANGE (%Change)	Day High	Volume (% DAV) (% 50 day avg vol)	52 Wk Hi % From Hi	Featured Date	Price Featured	Pivot Featured
								Max Buy
ACT - NYSE Actavis plc Medical-Generic Drugs	$296.43	-1.19 -0.40%	$299.77	4,494,828 131.39% of 50 DAV 50 DAV is 3,421,000	$317.72 -6.70%	12/29/2014	$260.22	PP = $272.85
								MB = $286.49
Most Recent Note - 4/1/2015 5:38:17 PM G - Slumped near its 50 DMA line with higher volume today. Completed a new Public Offering on 2/25/15. Reported Dec '14 earnings +23%, below the +25% minimum guideline (C criteria) of the fact-based investment system. Its 50 DMA line ($290) defines support where violations would raise more serious concerns. See the latest FSU analysis for more details and new annotated graphs. >>> FEATURED STOCK ARTICLE : Pullback With Higher Volume Toward 50-Day Moving Average - 4/1/2015 View all notes \| Set NEW NOTE alert \| CANSLIM.net Company Profile \| SEC News \| Chart \| Request a new note C A N S L I M
AKAM - NASDAQ Akamai Technologies Inc INTERNET - Internet Software and Services	$70.31	-0.74 -1.03%	$70.98	1,209,833 73.19% of 50 DAV 50 DAV is 1,653,000	$73.53 -4.38%	2/13/2015	$68.46	PP = $65.49
								MB = $68.76
Most Recent Note - 3/30/2015 7:31:03 PM G - Consolidating with volume totals cooling. Recent lows highs in the $68.50 area define near-term support above its 50 DMA line. >>> FEATURED STOCK ARTICLE : Wedging Gains Have Followed Brief Consolidation - 3/23/2015 View all notes \| Set NEW NOTE alert \| CANSLIM.net Company Profile \| SEC News \| Chart \| Request a new note C A N S L I M
AMBA - NASDAQ Ambarella Inc ELECTRONICS - Semiconductor - Specialized	$73.97	-1.74 -2.30%	$74.89	1,778,730 92.59% of 50 DAV 50 DAV is 1,921,000	$77.39 -4.42%	3/2/2015	$60.54	PP = $63.30
								MB = $66.47
Most Recent Note - 4/1/2015 12:15:21 PM G - Pulling back today following 3 consecutive gains and a move into new high territory. It is too extended to be bought under the guidelines. Prior highs near $63 define important near term support to watch. See the latest FSU analysis for more details and annotated graphs. >>> FEATURED STOCK ARTICLE : Getting Extended After Brief Pullback - 3/30/2015 View all notes \| Set NEW NOTE alert \| CANSLIM.net Company Profile \| SEC News \| Chart \| Request a new note C A N S L I M
EPAM - NYSE Epam Systems Inc COMPUTER SOFTWARE and SERVICES - Information Technology Service	$61.40	+0.11 0.18%	$61.80	374,037 105.07% of 50 DAV 50 DAV is 356,000	$63.50 -3.31%	3/27/2015	$61.97	PP = $63.60
								MB = $66.78
Most Recent Note - 3/27/2015 5:40:31 PM Y - Color code is changed to yellow with new pivot point cited based on its 2/27/15 high while building a short flat base. Subsequent volume-driven gains above the pivot point may trigger a new (or add-on) technical buy signal. Stubbornly holding its ground well above prior highs and its 50 DMA line defining support to watch on pullbacks. >>> FEATURED STOCK ARTICLE : Hovering Near Highs Extended From Prior Base - 3/18/2015 View all notes \| Set NEW NOTE alert \| CANSLIM.net Company Profile \| SEC News \| Chart \| Request a new note C A N S L I M
FB - NASDAQ Facebook Inc Cl A INTERNET	$81.67	-0.55 -0.67%	$82.72	22,018,707 82.70% of 50 DAV 50 DAV is 26,626,000	$86.07 -5.12%	2/20/2015	$81.79	PP = $78.47
								MB = $82.39
Most Recent Note - 3/31/2015 6:13:14 PM G - Consolidating above prior resistance in the $82 area defining important near-term support above the 50 DMA line. See the latest FSU analysis for more details and new annotated graphs. >>> FEATURED STOCK ARTICLE : Pullback Near Previously Stubborn Resistance - 3/31/2015 View all notes \| Set NEW NOTE alert \| CANSLIM.net Company Profile \| SEC News \| Chart \| Request a new note C A N S L I M
Symbol/Exchange Company Name Industry Group	PRICE	CHANGE (%Change)	Day High	Volume (% DAV) (% 50 day avg vol)	52 Wk Hi % From Hi	Featured Date	Price Featured	Pivot Featured
								Max Buy
ILMN - NASDAQ Illumina Inc DRUGS - Biotechnology	$182.21	-3.43 -1.85%	$186.32	1,164,704 105.69% of 50 DAV 50 DAV is 1,102,000	$213.33 -14.59%	12/30/2014	$186.26	PP = $196.00
								MB = $205.80
Most Recent Note - 3/30/2015 7:35:16 PM G - Halted its slide at its 200 DMA line but recent gains have lacked great volume conviction. Its Relative Strength rating has slumped to 73, below the 80+ minimum guideline for buy candidates. Needs gains above the 50 DMA line for its outlook to improve. >>> FEATURED STOCK ARTICLE : Relative Strength Rating Falls While Testing 200-Day Average - 3/25/2015 View all notes \| Set NEW NOTE alert \| CANSLIM.net Company Profile \| SEC News \| Chart \| Request a new note C A N S L I M
JLL - NYSE Jones Lang Lasalle Inc REAL ESTATE - Property Management/Developmen	$171.11	+0.71 0.42%	$171.32	328,637 107.40% of 50 DAV 50 DAV is 306,000	$170.85 0.15%	2/3/2015	$156.95	PP = $154.66
								MB = $162.39
Most Recent Note - 3/30/2015 7:38:38 PM G - It is extended from its prior base and found support above prior highs on the recent pullback. The 50 DMA line ($159) defines the next important support level to watch. >>> FEATURED STOCK ARTICLE : Found Support Near Prior Highs and 50-Day Moving Average Line - 3/17/2015 View all notes \| Set NEW NOTE alert \| CANSLIM.net Company Profile \| SEC News \| Chart \| Request a new note C A N S L I M
LNKD - NYSE Linkedin Corp Class A INTERNET - Internet Information Providers	$248.32	-1.54 -0.62%	$251.05	1,114,175 74.28% of 50 DAV 50 DAV is 1,500,000	$276.18 -10.09%	2/6/2015	$269.83	PP = $243.35
								MB = $255.52
Most Recent Note - 3/30/2015 7:48:37 PM G - Quietly slumped below prior lows and it is testing its 50 DMA line ($253.29) defining near-term support. Stalled and made no progress since the considerable "breakaway gap" noted in the 2/06/15 mid-day report (read here). >>> FEATURED STOCK ARTICLE : Stalled Following "Breakaway Gap" 6 Weeks Ago - 3/19/2015 View all notes \| Set NEW NOTE alert \| CANSLIM.net Company Profile \| SEC News \| Chart \| Request a new note C A N S L I M
NXPI - NASDAQ Nxp Semiconductors N V ELECTRONICS - Semiconductor - Broad Line	$99.75	-0.61 -0.61%	$100.65	3,301,548 84.57% of 50 DAV 50 DAV is 3,904,000	$108.50 -8.06%	1/5/2015	$76.43	PP = $78.44
								MB = $82.36
Most Recent Note - 3/30/2015 7:40:48 PM G - It is very extended from its prior base, and disciplined investors avoid chasing extended stocks. Recent lows ($93.05 on 3/26/15) and the 50 DMA line ($89.97) define important near-term support to watch on pullbacks. >>> FEATURED STOCK ARTICLE : Pullback Following Considerable Rally of 41.9% Since Start of Year - 3/26/2015 View all notes \| Set NEW NOTE alert \| CANSLIM.net Company Profile \| SEC News \| Chart \| Request a new note C A N S L I M
PANW - NYSE Palo Alto Networks Computer Sftwr-Security	$141.53	-4.55 -3.11%	$146.44	2,467,930 177.42% of 50 DAV 50 DAV is 1,391,000	$150.44 -5.92%	3/27/2015	$146.44	PP = $149.45
								MB = $156.92
Most Recent Note - 4/1/2015 5:40:14 PM Y - Encountering distributional pressure after recently wedging to a new high (N criteria) with gains backed by sub par volume. Members were recently reminded - "Stocks should have at least +40%* above average volume while rising above the pivot point to clinch a proper new (or add-on) technical buy signal."* >>> FEATURED STOCK ARTICLE : Latest Consolidation is a Short New "Square Box" Base - 3/27/2015 View all notes \| Set NEW NOTE alert \| CANSLIM.net Company Profile \| SEC News \| Chart \| Request a new note C A N S L I M
Symbol/Exchange Company Name Industry Group	PRICE	CHANGE (%Change)	Day High	Volume (% DAV) (% 50 day avg vol)	52 Wk Hi % From Hi	Featured Date	Price Featured	Pivot Featured
								Max Buy
QLYS - NASDAQ Qualys Inc Computer Sftwr-Security	$47.05	+0.57 1.23%	$47.64	269,731 66.93% of 50 DAV 50 DAV is 403,000	$50.00 -5.90%	2/6/2015	$42.24	PP = $40.84
								MB = $42.88
Most Recent Note - 3/30/2015 7:20:19 PM G - Its 50 DMA line ($43.92) and prior lows in the $42 area define near-term support to watch. More damaging losses would raise concerns. >>> FEATURED STOCK ARTICLE : Consolidating Above Support at Prior Highs and 50-Day Moving Average - 3/20/2015 View all notes \| Set NEW NOTE alert \| CANSLIM.net Company Profile \| SEC News \| Chart \| Request a new note C A N S L I M
REIS - NASDAQ Reis Inc Real Estate Dvlpmt/Ops	$25.62	-0.02 -0.08%	$25.74	18,297 60.99% of 50 DAV 50 DAV is 30,000	$28.82 -11.10%	3/16/2015	$25.65	PP = $26.64
								MB = $27.97
Most Recent Note - 3/31/2015 1:13:08 PM Y - Down on higher volume today - action indicative of distributional pressure. Hit a new 52-week high and rallied above its pivot point but with volume only +28% above average on the prior session. No resistance remains due to overhead supply. Gains above the pivot point must have at least +40% above average volume to trigger a convincing technical buy signal. Pyramiding is a tactic taught in the Certification that allows investors to let market action help to dictate entries and weighting into each new position purchased. >>> FEATURED STOCK ARTICLE : Found Support at Long-Term Average and Fundamentals Are Good - 3/16/2015 View all notes \| Set NEW NOTE alert \| CANSLIM.net Company Profile \| SEC News \| Chart \| Request a new note C A N S L I M
VRX - NYSE Valeant Pharmaceuticals DRUGS - Drug Manufacturers - Other	$197.39	-1.23 -0.62%	$198.50	1,876,147 57.48% of 50 DAV 50 DAV is 3,264,000	$206.84 -4.57%	1/5/2015	$144.84	PP = $149.90
								MB = $157.40
Most Recent Note - 3/30/2015 7:46:10 PM G - Completed a new Public Offering on 3/17/15 while consolidating near its all-time high. Earnings for Dec '14 quarter raised concerns. Its recent low ($186.20 on 3/11/15) and its 50 DMA line ($182.27) define near-term support to watch. >>> FEATURED STOCK ARTICLE : Fundamental Concerns Raised by Weaker Earnings and Sales Increases - 3/24/2015 View all notes \| Set NEW NOTE alert \| CANSLIM.net Company Profile \| SEC News \| Chart \| Request a new note C A N S L I M

THESE ARE NOT BUY RECOMMENDATIONS! Comments contained in the body of this report are technical opinions only. The material herein has been obtained from sources believed to be reliable and accurate, however, its accuracy and completeness cannot be guaranteed. This site is not an investment advisor, hence it does not endorse or recommend any securities or other investments. Any recommendation contained in this report may not be suitable for all investors and it is not to be deemed an offer or solicitation on our part with respect to the purchase or sale of any securities. All trademarks, service marks and trade names appearing in this report are the property of their respective owners, and are likewise used for identification purposes only.

This report is a service available only to active Paid Premium Members. You may opt-out of receiving report notifications at any time. Questions or comments may be submitted by writing to Premium Membership Services 665 S.E. 10 Street, Suite 201 Deerfield Beach, FL 33441-5634 or by calling 1-800-965-8307 or 954-785-1121.